Vyndaqel

Tafamidis Meglumine

8.2 High risk

Vyndaqel & Death

28.2%

of users reported Death

91.6%

also reported Death

83.9%

are men

Most common medical consequences

Death
91.6%
Severe reaction
6.7%
Hospitalization
1.7%

Have you experienced any negative side effects from this medication?

Vyndaqel: general information

Most common side effects (51)

Most commonly affected ages

60 - 69 years
9.1%
70 - 79 years
37.5%
80 - 89 years
47.2%
90 - 99 years
6.2%